Summary
α-FP was determined by radioimmunoassay in the serum of 28 normal subjects aged between 21 and 40 and in the serum of 27 male subjects aged between 19 and 49 with acute hepatitis. The measurements made on the hepatitis cases were systematically repeated during the course of the disease from the 5th day after its clinical appearance to the 30th–45th day; at the same time the behaviour of GPT, alkaline phosphatase and bilirubinemia was also studied. In normal adult subjects, α-FP was constantly present with a mean value of 1.37±0.67 in males and 1.10±0.63 in females; no statistically significant difference was found between the two sexes. In the hepatitis cases α-FP was found in significantly higher quantities than the normal mean values; it increased progressively to reach amaximum on about the 15th–20th day from the clinical onset, and then decreased quite rapidly remaining, however, at a level higher than normal for the whole observation period. The findings confirm the persistence of the α-FP synthesis in the normal adult subject and reveal an increase in this synthesis in the course of acute hepatitis, possibly linked to the process of hepatic regeneration, but without this synthesis being correlated with the behaviour of the other serum parameters (GPT, alkaline phosphatase, bilirubin).
Similar content being viewed by others
References
Abelev G. I.: Alpha-Fetoprotein in Ontogenesis and Its Association with Malignant Tumors — Advanc. Cancer Res.14, 295, 1971.
Alpert E., Hershberg R., Schur P., Isselbacher K. J.: α-Fetoprotein in Human Hepatoma: Improved Detection in Serum, and Quantitative Studies Using a New Sensitive Technique — Gastroenterology61, 137, 1971.
Chayvialle J. A. P., Ganguli P. C.: Radioimmunoassay of Alpha-Fetoprotein in Human Plasma — Lancet2, 1355, 1973.
Hausmaen T. U., Helger R., Rick W., Gross W.: Optimal Conditions for the Determination of Serum Alkaline Phosphatase by a New Kinetic Method — Clin. chim. Acta15, 241, 1967.
Hirai H., Nishi S., Watabe H.: Radioimmunoassay of Alpha-Fetoprotein (Alpha F) — Protides biol. Fluids20, 1, 1972.
Huguet C., Gallot D., Hirsch-Marie H., Caroli J.: Serum Alpha-Fetoprotein in Malignant Hepatoma — Lancet (Letter)2, 1343, 1974.
Jendrassik L., Clephorn R. A.: Photometrische Bilirubinbestimmung — Biochem. Z.289, 1, 1936.
Karmen A., Wroblewski F., La Due J. S.: Transaminase Activity in Human Blood — J. clin. Invest.34, 126, 1955.
Karvountzis G. G., Redeker A. G.: Relation of Alpha-Fetoprotein in Acute Hepatitis to Severity and Prognosis — Ann. intern. Med.80, 156, 1974.
Kew M. C., Purves R. L., Bersohn I.: Serum Alpha-Fetoprotein Levels in Acute Viral Hepatitis — Gut14, 939, 1973.
Koestner A.: Transplacental Carcinogenesis — In: Proc. of 10th Canadian Cancer Research Conference, 1973; p. 65.
Lehmann F. G., Lehmann D.: α-Foetoprotein in malignen Tumoren — Klin. Wschr.52, 222, 1974.
Masopust J., Kithier K., Radi J., Kouhcky J., Koiai I.: Occurrence of Fetoprotein in Patients with Neoplasms and Non-Neoplastic Diseases — Int. J. Cancer3, 364, 1968.
Masseyeff R.: Human Alpha-Feto-Protein — Path. et Biol.20, 703, 1972.
Masseyeff R.: Factors of Alpha-Feto-Protein Biosynthesis in Man — La Ricerca Clin. Lab.3 (Suppl.), 27, 1973.
Prince A. M.: The High Voltage Immuno-Electrosmophoretic (IEOP) Technique for Detection of SH Antigen: Application to Blood Donor Screening and to Study of Liver Disease — Vox Sang. (Basel)19, 205, 1970.
Prince A. M., Brotman B., Jass D., Ikram H.: Specificity of the Direct Solid-Phase Radioimmunoassay for Detection of Hepatitis-B Antigen — Lancet2, 1346, 1973.
Purves L. R., Branch W. R., Geddes F. W., Manso C., Portugal M.: Serum Alpha-Fetoprotein. VII. The Range of Apparent Serum Values in Normal People, Pregnant Women and Primary Liver Cancer High Risk Populations — Cancer (Amst.)31, 578, 1973.
Purves L. R., Geddes F. W.: A More Sensitive Test for Alpha-Fetoprotein — Lancet (Letter)1, 47, 1972.
Ruoslahti E., Salaspuro M., Pihko H., Andersson L., Seppälä M.: Serum-Fetoprotein: Diagnostic Significance in Liver Disease — Brit. med. J.2, 527, 1974.
Ruoslahti E., Seppälä M.: Studies of Carcino-Fetal Proteins. III. Development of a Radioimmunoassay for α-Fetoprotein. Demonstration of α-Fetoprotein in Serum of Healthy Human Adults — Int. J. Cancer8, 383, 1971.
Ruoslahti E., Seppälä M.: α-Fetoprotein in Normal Human Serum — Nature (Lond.)21, 235, 1972.
Ruoslahti E., Seppälä M.: Normal and Increased Alpha-Fetoprotein in Neoplastic and Non-Neoplastic Liver Disease — Lancet (Letter)2, 278, 1972.
Ruoslahti E., Seppälä M., Vuopio P., Saksela E., Peltokallio P.: Radio-Immunoassay of Alpha-Fetoprotein in Primary and Secondary Cancer of the Liver — J. nat. Cancer Inst.49, 623, 1972.
Sell S., Nichols M., Becker F. F., Leffert H. L.: Hepatocyte Proliferation and α-Fetoprotein in Pregnant, Neonatal, and Partially Hepatectomized Rats — Cancer Res.34, 865, 1974.
Sherlock S., Fox R. A., Niazi S. P., Scheuer P. J.: Chronic Liver Disease and Primary Liver-Cell Cancer with Hepatitis-Associated (Australia) Antigen in Serum — Lancet1, 1243, 1970.
Silver H. K. B., Deneault J., Gold P., Thompson W. G., Shuster J., Freedman S. O.: The Detection of α-Fetoprotein in Patients with Viral Hepatitis — Cancer Res.34, 244, 1974.
Silver H. K. B., Gold P., Shuster J., Javitt N. B., Freedman S. O., Finlyson N. D. C.: Alpha-Fetoprotein in Chronic Liver Disease — New Engl. J. Med.5, 506, 1974.
Smith J. B.: Occurrence of Alpha-Fetoprotein in Acute Viral Hepatitis — Int. J. Cancer8, 421, 1971.
Smith J. B., Lewellys F. B.: α-Fetoprotein and Liver-Specific Antigen in Viral Hepatitis Type B — Arch. intern. Med.133, 437, 1974.
Uriel J., de Nechaud B.: La recherche d‘alpha-foetoprotéine en pathologie humaine. État actuel de la question — Ann. Inst. Pasteur122, 829, 1972.
Uriel J., de Nechaud B., Stanislawski-Birencwajg M., Masseyeff R., Leblanc L., Quenum C., Loisillier F., Grabar P.: Le diagnostic du cancer primaire du foie par des méthodes immunologiques — Presse méd.28, 1415, 1968.
Velasco M., Sorensen R., Daiber A., Carmona A., Katz R.: Primary Carcinoma of the Liver Associated with Australia Antigen — Lancet2, 1183, 1971.
Vogel C. L., Anthony P. P., Mody N., Barker L. E.: Hepatitis-Associated Antigen in Ugandan Patients with Hepatocellular Carcinoma — Lancet2, 621, 1970.
Wroblewski F., Cabaud P.: Colorimetric Measurement of Serum Glutamic-Pyruvic Transaminase — Amer. J. clin. Path.27, 235, 1957.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gaidano, G., Berta, L., Boccuzzi, G. et al. Behaviour of serum α-fetoprotein in acute hepatitis. La Ricerca in Clin. Lab. 5, 321–328 (1975). https://doi.org/10.1007/BF02910156
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02910156